The FDA approved changes to the labels for six menopausal hormone therapy products in a move the agency said clarifies risk ...
The FDA has lifted longstanding and the most severe warnings off of hormone replacement therapies for menopausal women.
Hosted on MSN
AI at the FDA: help or hindrance?
The advent of AI at the US Food and Drug Administration (FDA) is changing the complexion of the regulatory approval process for medical devices. In May, FDA commissioner Dr Martin Makary announced ...
The U.S. Food and Drug Administration has given marketing clearance to a blood test to help diagnose Alzheimer’s disease, making the test the first to get signoff to aid in the early detection of the ...
The U.S. FDA has granted orphan drug designation to HCB101, an investigational immunotherapy, for the treatment of gastric cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results